[1] Merched AJ, Ko K, Gotlinger KH, et al.Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators[J]. FASEB J, 2008,22(10):3595-3606. [2] Cipollone F, Mezzetti A, Fazia ML, et al.Association between 5- lipoxygenase expression and plaque instability in humans[J]. Arterioscler Thromb Vasc Biol, 2005, 25:1665-1670. [3] Kriszbacher I, Koppán M, Bódis J.Inflammation,atherosclerosis, and coronary artery disease[J]. N Engl J Med, 2005, 353(4):429-430. [4] 李玉洁, 杨庆, 翁小刚, 等. 动脉粥样硬化炎症信号通路研究进展[J]. 中国药理学通报, 2009, 25(7):857-860. [5] Lotzer K, Funk CD, Habenicht AJ.The 5-lipoxygenase pathway in arterial wall biology and atherosclerosis[J]. Biochem Biophys Acta, 2005, 1736(1):30-37. [6] 张梅英, 吴红联, 杨葳, 等. 5-脂氧化酶转基因小鼠模型的制备[J]. 中国实验动物学报, 2010, 18(1):60-64. [7] Jawien J, Korbut R.The current view on the role of leukotrienes in atherogenesis[J]. J Physiol Pharmacol, 2010, 61(6):647-650. [8] 梅卫义, 杜志民, 胡承恒, 等. 妊娠相关血浆蛋白A水平与 不稳定心绞痛患者冠状动脉狭窄病变形态的关系[J]. 中山大学学报: 医学科学版, 2005, 24(4):456-458. [9] Andrae J, Dallini R, Betsholtz C.Role of platelet derived growth factors in physiology and medicine[J]. Gene Dev, 2008, 22(10):1276-1312. [10] Brand K, Page S, Rogler G, et al.Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion[J]. J Clin Invest, 1996, 97(7):1715-1722. |